IP vs NTLA
International Paper (IP) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the IP and NTLA stock pages for the full models.
Not investment advice.